Cell and gene therapies (ATMPs)

Advanced Therapy Medicinal Products (ATMPs) are medicinal product based on genes, cells and/or tissues. ATMPs are used in the treatment of several diseases, including malignancies,  genetic abnormalities, viral infections, degenerative disorders and (auto)immune diseases. The GMP facility of the LUMC facilitates the pharmaceutical development of these cell therapies. We have the infrastructure and a team of specialists focussed on the cell and gene therapy product development, who will work with you when you need us, to get the best possible results. We work with you to accelerate your projects, helping your cell and gene therapies to be safer, more effective and affordable.

Products:

Mesenchymal Stem Cells, Tumor Infiltrating T cells, Virus-specific T cells, Tolerogenic Dendritic Cells. 

Facility and Equipment: 

  • Clean room complex
  • GMP manufacturing licence
  • In house QP 
  • Quality system
  • Storage facility 

Experts:

Dr. A.G.T. Terwisscha van Scheltinga 
Dr. P. Meij